Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
ESC Heart Fail ; 8(2): 1643-1648, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33634606

RESUMO

Since the establishment of highly active antiretroviral therapy, survival rates have improved among patients with human immunodeficiency virus infection giving them the possibility to become transplant candidates. Recent publications revealed that human immunodeficiency virus-positive heart transplant recipients' survival is similar to non-infected patients. We present the case of a 40-year-old human immunodeficiency virus infected patient, who was hospitalized due to severely decreased left ventricular function with a possible aetiology of acute myocarditis, that has later been confirmed by histological investigation of myocardial biopsy. Due to rapid progression to refractory cardiogenic shock, extracorporeal membrane oxygenation implantation had been initiated, which was upgraded to biventricular assist device later. On the 35th day of upgraded support, the patient underwent heart transplantation uneventfully. Our clinical experience confirms that implementation of temporary mechanical circulatory support and subsequent cardiac transplantation might be successful in human immunodeficiency virus-positive patients even in case of new onset, irreversible acute heart failure.


Assuntos
Transplante de Coração , Coração Auxiliar , Miocardite , Adulto , HIV , Humanos , Miocardite/complicações , Miocardite/diagnóstico , Choque Cardiogênico/etiologia , Choque Cardiogênico/terapia
2.
Europace ; 14(4): 599-604, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22194467

RESUMO

AIM: Failure rate to implant left ventricular (LV) lead transvenously is 4-8% in cardiac resynchronization therapy (CRT) patients. Epicardial lead placement is an alternative method and if not applicable case reports and small series showed the feasibility of endocardial LV lead implantation. Electroanatomical mapping might be a useful tool to guide this procedure. METHODS AND RESULTS: Four patients had undergone endocardial LV lead implantation after unsuccessful transvenous implantation or epicardial LV lead dysfunction using the transseptal approach. Electroanatomical mapping was used to mark the location of the transseptal puncture. This location point guided the mapping catheter from the subclavian access and facilitated positioning of the LV lead at the adjacent latest activation area of the left ventricle detected by activation mapping. Endocardial active fixation LV leads were successfully implanted in all patients with stable electrical parameters immediately after implantation and over a mean follow-up of 18.3 months (lead impedance 520 ± 177 vs. 439 ± 119 Ω and pacing threshold 0.8 ± 0.2 V, 0.5 ms vs. 0.6 ± 0.1 V, 0.5 ms, respectively). Patients were maintained on anticoagulation therapy with a target international normalized ratio of 3.5-4.5 and did not show any thromboembolic, haemorrhagic events, or infection. Echocardiography showed significant improvement of LV systolic function with marked improvement of the functional status. CONCLUSIONS: Electroanatomical mapping is a useful technical tool to guide endocardial LV lead implantation. It helps to identify the location of the transseptal puncture and the use of activation mapping might facilitate location of the optimal lead positions during CRT.


Assuntos
Mapeamento Potencial de Superfície Corporal/métodos , Terapia de Ressincronização Cardíaca/métodos , Eletrodos Implantados , Insuficiência Cardíaca/diagnóstico , Insuficiência Cardíaca/prevenção & controle , Ventrículos do Coração/cirurgia , Cirurgia Assistida por Computador/métodos , Idoso , Dispositivos de Terapia de Ressincronização Cardíaca , Endocárdio/cirurgia , Feminino , Septos Cardíacos/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Implantação de Prótese/métodos
3.
Orv Hetil ; 152(5): 171-81, 2011 Jan 30.
Artigo em Húngaro | MEDLINE | ID: mdl-21247858

RESUMO

Therapeutic use of hypothermia has come to the frontline in the past decade again in the prevention and in mitigation of neurologic impairment. The application of hypothermia is considered as a successful therapeutic measure not just in neuro- or cardiac surgery, but also in states causing brain injury or damage. According to our present knowledge this is the only proven therapeutic tool, which improves the neurologic outcome after cardiac arrest, decreasing the oxygen demand of the brain. Besides influencing the nervous system, hypothermia influences the function of the whole organ system. Beside its beneficial effects, it has many side-effects, which may be harmful to the patient. Before using it for a therapeutic purpose, it is very important to be familiar with the physiology and complications of hypothermia, to know, how to prevent and treat its side-effects. The purpose of this article is to summarize the physiologic and pathophysiologic effects of hypothermia.


Assuntos
Lesões Encefálicas/terapia , Cuidados Críticos/métodos , Parada Cardíaca/terapia , Hipotermia Induzida , Hipotermia/fisiopatologia , Animais , Regulação da Temperatura Corporal , Encéfalo/metabolismo , Encéfalo/fisiologia , Encéfalo/fisiopatologia , Lesões Encefálicas/complicações , Lesões Encefálicas/fisiopatologia , Fenômenos Fisiológicos Cardiovasculares , Cuidados Críticos/normas , Fenômenos Fisiológicos do Sistema Digestório , Eletrocardiografia , Parada Cardíaca/complicações , Parada Cardíaca/fisiopatologia , Homeostase , Humanos , Hipotermia Induzida/efeitos adversos , Fenômenos Fisiológicos do Sistema Nervoso , Consumo de Oxigênio , Fenômenos Fisiológicos Respiratórios , Equilíbrio Hidroeletrolítico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA